Global Tumor Fluid Biopsy Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Tumor Fluid Biopsy Market Research Report 2024
According to Mr Accuracy reports new survey, global Tumor Fluid Biopsy market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Tumor Fluid Biopsy market research.
Global spending on oncology drugs will reach $185 billion in 2021 and is expected to exceed $300 billion by 2026, driven by continued innovation. Spending growth is driven by a combination of factorssurging sales of new products and branded drugs; loss of market exclusivity for pharmaceuticals; and the impact of biosimilars. The United States remains the world's largest market for oncology drugs, followed by major countries in Europe. Under the combined effect of accelerated popularization of new treatments and falling prices, China's spending on oncology drugs in 2021 will be higher than that of other emerging markets combined.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Tumor Fluid Biopsy market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Exact Science
Cellmax Life
Burning Rock Biotech
Berry Genomics Co
HaploX Biotechnology Co
New Horizon Health Limited
Genetronhealth
Amoy Diagnostics Co
Guangzhou Wondfo Biotech
YZY Biopharma
GenoploRare
Segment by Type
CTDNA Detection
CTC Detection
Other
Hospital
Third Party Organization
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Tumor Fluid Biopsy report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source
Global spending on oncology drugs will reach $185 billion in 2021 and is expected to exceed $300 billion by 2026, driven by continued innovation. Spending growth is driven by a combination of factorssurging sales of new products and branded drugs; loss of market exclusivity for pharmaceuticals; and the impact of biosimilars. The United States remains the world's largest market for oncology drugs, followed by major countries in Europe. Under the combined effect of accelerated popularization of new treatments and falling prices, China's spending on oncology drugs in 2021 will be higher than that of other emerging markets combined.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Tumor Fluid Biopsy market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Exact Science
Cellmax Life
Burning Rock Biotech
Berry Genomics Co
HaploX Biotechnology Co
New Horizon Health Limited
Genetronhealth
Amoy Diagnostics Co
Guangzhou Wondfo Biotech
YZY Biopharma
GenoploRare
Segment by Type
CTDNA Detection
CTC Detection
Other
Segment by Application
Hospital
Third Party Organization
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Tumor Fluid Biopsy report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source